Literature DB >> 12052831

Phosphorylation of VP30 impairs ebola virus transcription.

Jens Modrof1, Elke Mühlberger, Hans-Dieter Klenk, Stephan Becker.   

Abstract

Transcription of the highly pathogenic Ebola virus (EBOV) is dependent on VP30, a constituent of the viral nucleocapsid complex. Here we present evidence that phosphorylation of VP30, which takes place at six N-terminal serine residues and one threonine residue, is of functional significance. Replacement of the phosphoserines by alanines resulted in an only slightly phosphorylated VP30 (VP30(6A)) that is still able to activate EBOV-specific transcription in a plasmid-based minigenome system. VP30(6A), however, did not bind to inclusions that are induced by the major nucleocapsid protein NP. Three intracellular phosphatases (PP1, PP2A, and PP2C) have been determined to dephosphorylate VP30. The presence of okadaic acid (OA), an inhibitor of PP1 and PP2A, had the same negative effect on transcription activation by VP30 as the substitution of the six phosphoserines for aspartate residues. OA, however, did not impair transcription when VP30 was replaced by VP30(6A). In EBOV-infected cells, OA blocked virus growth dose-dependently. The block was mediated by the extensive phosphorylation of VP30, which is evidenced by the result that expression of VP30(6A), in trans, led to the progression of EBOV infection in the presence of OA. In conclusion, phosphorylation of VP30 was shown to regulate negatively transcription activation and positively binding to the NP inclusions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12052831     DOI: 10.1074/jbc.M203775200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription.

Authors:  Peggy Möller; Nonia Pariente; Hans-Dieter Klenk; Stephan Becker
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Functional mapping of the nucleoprotein of Ebola virus.

Authors:  Shinji Watanabe; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association.

Authors:  Bettina Hartlieb; Tadeusz Muziol; Winfried Weissenhorn; Stephan Becker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

4.  The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified.

Authors:  A Groseth; J E Charton; M Sauerborn; F Feldmann; S M Jones; T Hoenen; H Feldmann
Journal:  Virus Res       Date:  2008-12-16       Impact factor: 3.303

5.  Live-cell imaging of Marburg virus-infected cells uncovers actin-dependent transport of nucleocapsids over long distances.

Authors:  Gordian Schudt; Larissa Kolesnikova; Olga Dolnik; Beate Sodeik; Stephan Becker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

6.  Filovirus replication and transcription.

Authors:  Elke Mühlberger
Journal:  Future Virol       Date:  2007-03       Impact factor: 1.831

Review 7.  Epidemiology and Management of the 2013-16 West African Ebola Outbreak.

Authors:  M L Boisen; J N Hartnett; A Goba; M A Vandi; D S Grant; J S Schieffelin; R F Garry; L M Branco
Journal:  Annu Rev Virol       Date:  2016-08-15       Impact factor: 10.431

8.  The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.

Authors:  Martina Trunschke; Dominik Conrad; Sven Enterlein; Judith Olejnik; Kristina Brauburger; Elke Mühlberger
Journal:  Virology       Date:  2013-04-11       Impact factor: 3.616

9.  Role of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription.

Authors:  Philipp A Ilinykh; Bersabeh Tigabu; Andrey Ivanov; Tatiana Ammosova; Yuri Obukhov; Tania Garron; Namita Kumari; Dmytro Kovalskyy; Maxim O Platonov; Vasiliy S Naumchik; Alexander N Freiberg; Sergei Nekhai; Alexander Bukreyev
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

10.  High-Throughput Minigenome System for Identifying Small-Molecule Inhibitors of Ebola Virus Replication.

Authors:  Megan R Edwards; Colette Pietzsch; Thibaut Vausselin; Megan L Shaw; Alexander Bukreyev; Christopher F Basler
Journal:  ACS Infect Dis       Date:  2015-06-24       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.